Rochester, MN - A case report of a patient who suffered erosion of an Amplatzer septal-occluder device (St Jude Medical) six years after it was implanted, resulting in cardiac tamponade and ...

The US Food and Drug Administration (FDA) on Friday approved Minnesota-based St. Jude Medical’s Amplatzer PFO Occluder, which is intended to reduce the risk of a stroke for some patients who ...

The new study published in Heart Rhythm details this alternative method to the conventional treatment of implementing a percutaneous metal device for PFO closure, which is associated with adverse ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The population of patients undergoing patent foramen ovale (PFO) closure in the US doesn’t match those of the clinical trials that formed the basis of the US Food and Drug Administration’s approval of ...

We postulated that cryoablation can also fuse PFO by injuring the primary and secondary septum." Although AF and PFO are both risk factors for stroke/TIA, it is difficult to determine whether PFO is ...